Evaluating skin tone scales for dermatologic dataset labeling: a prospective-comparative study
Skin tone affects artificial intelligence (AI) performance in dermatology. While labeling datasets for skin tone could improve algorithm generalizability for detecting dermatologic malignancies, large-scale validation of skin tone assessments is lacking. This prospective observational study assessed reliability of subjective tools (Fitzpatrick Skin Type [FST], Monk Skin Tone [MST], Pantone SkinTone Guide) and an objective colorimeter for in-person and photography-based settings to evaluate utility for labeling dermoscopic datasets. Colorimetry (gold standard for color measurement) demonstrated high precision with in-person measurements. Of subjective scales, MST demonstrated slightly tighter clustering in the color space and high repeatability for in-person and photography-based assessments (latter varied by lighting). Dermoscopic image-extracted color values correlated poorly with colorimetry values. For subjective ratings, MST more effectively captured differences in AI melanoma classification scores than FST. Findings underscore that FST is not a proxy for skin tone; an important role remains for skin tone assessment to improve AI performance.
Authors
- Kamaria N. Nelson
- Allan C. Halpern (ORCID: https://orcid.org/0000-0001-7320-1901)
- Vanessa R. Weir (ORCID: https://orcid.org/0000-0002-7338-4784)
- Nicholas R. Kurtansky (ORCID: https://orcid.org/0000-0002-6745-0386)
- Trina Salvador
- Jenna Lester
- Veronica Rotemberg (ORCID: https://orcid.org/0000-0003-0639-2677)
- Maura C. Gillis
- Yingjoy Li
Institutions
- Beth Israel Deaconess Medical Center (US)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of California, San Francisco (US)
Publication Details
- Journal
- npj Digital Medicine
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1038/s41746-025-02245-2
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Prevent Cancer Foundation
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health
- National Cancer Institute